FDA approvaloutcome: successconf 1.00

myqorzo — FDA approval

$CYTK · CYTOKINETICS INC

Event date

December 19, 2025

169 days ago

Sponsor runway

3 mo

$129.8M liquid

Evidence

“openFDA ORIG (TYPE 1) approval of MYQORZO — application NDA219083”

Source ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)

Ticker	Drug	Date	Outcome
$INCY	zynyz	2026-05-18	success
$INCY	jakafi xr	2026-05-01	success
$AXSM	auvelity	2026-04-30	success
$INCY	zynyz	2026-03-30	success
$BIIB	spinraza	2026-03-27	success
$CORT	lifyorli	2026-03-25	success
$RYTM	imcivree	2026-03-19	success
$ASND	yuviwel	2026-02-27	success
$BMRN	palynziq	2026-02-27	success
$ETON	desmoda	2026-02-25	success

Recent insider activity· ±90 days

12 insiders · 0 buys · 43 sells

Sell10b5-1

2026-03-18

Callos Andrew

EVP, Chief Commercial Officer

1,930 @ $62.07$120K

Sell

2026-03-17

Lee Sung

EVP, Chief Financial Officer

4,935 @ $62.15$307K

Sell

2026-03-17

Malik Fady Ibraham

EVP Research & Development

7,636 @ $62.15$475K

Sell

2026-03-17

Callos Andrew

EVP, Chief Commercial Officer

5,626 @ $62.15$350K

Sell

2026-03-17

Callos Andrew

EVP, Chief Commercial Officer

2,916 @ $62.15$181K

Sell

2026-03-17

Blum Robert I

President & CEO

23,928 @ $62.15$1.49M

Sell

2026-03-17

Malik Fady Ibraham

EVP Research & Development

4,397 @ $62.15$273K

Sell

2026-03-17

Blum Robert I

President & CEO

12,673 @ $62.15$788K

Sell10b5-1

2026-03-16

Callos Andrew

EVP, Chief Commercial Officer

1,709 @ $61.03$104K

Grant

2026-03-15

Lee Sung

EVP, Chief Financial Officer

20,646 @ ——

Grant

2026-03-15

Callos Andrew

EVP, Chief Commercial Officer

20,646 @ ——

Grant

2026-03-15

Callos Andrew

EVP, Chief Commercial Officer

13,320 @ ——

Grant

2026-03-15

Callos Andrew

EVP, Chief Commercial Officer

1,665 @ ——

Grant

2026-03-15

Callos Andrew

EVP, Chief Commercial Officer

29,480 @ ——

Grant

2026-03-15

Blum Robert I

President & CEO

1,665 @ ——

Grant

2026-03-15

Malik Fady Ibraham

EVP Research & Development

27,306 @ ——

Grant

2026-03-15

Malik Fady Ibraham

EVP Research & Development

1,665 @ ——

Grant

2026-03-15

Malik Fady Ibraham

EVP Research & Development

39,527 @ ——

Grant

2026-03-15

Hessekiel Jeffrey

Chief Legal & Admin Officer

22,820 @ ——

Grant

2026-03-15

Hessekiel Jeffrey

Chief Legal & Admin Officer

8,325 @ ——

Grant

2026-03-15

Hessekiel Jeffrey

Chief Legal & Admin Officer

20,646 @ ——

Grant

2026-03-15

Lee Sung

EVP, Chief Financial Officer

29,480 @ ——

Grant

2026-03-15

Lee Sung

EVP, Chief Financial Officer

1,665 @ ——

Grant

2026-03-15

Blum Robert I

President & CEO

111,864 @ ——

Grant

2026-03-15

Blum Robert I

President & CEO

75,258 @ ——

Sell

2026-03-09

Blum Robert I

President & CEO

7,931 @ $60.72$482K

Sell

2026-03-09

Callos Andrew

EVP, Chief Commercial Officer

2,582 @ $60.72$157K

Sell

2026-03-09

Malik Fady Ibraham

EVP Research & Development

2,907 @ $60.72$177K

Sell10b5-1

2026-03-05

Callos Andrew

EVP, Chief Commercial Officer

11,000 @ $61.88$681K

Sell10b5-1

2026-03-05

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $61.87$928K

Exercise10b5-1

2026-03-05

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $23.26$349K

Exercise10b5-1

2026-03-05

Callos Andrew

EVP, Chief Commercial Officer

11,000 @ $39.13$430K

Sell10b5-1

2026-03-02

PARSHALL B LYNNE

Director

5,000 @ $61.21$306K

Exercise10b5-1

2026-03-02

Callos Andrew

EVP, Chief Commercial Officer

886 @ $37.63$33K

Sell10b5-1

2026-03-02

Callos Andrew

EVP, Chief Commercial Officer

886 @ $61.62$55K

Exercise10b5-1

2026-02-05

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $23.26$349K

Sell10b5-1

2026-02-05

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $61.93$929K

Exercise10b5-1

2026-02-02

Callos Andrew

EVP, Chief Commercial Officer

886 @ $37.63$33K

Sell10b5-1

2026-02-02

Callos Andrew

EVP, Chief Commercial Officer

886 @ $62.10$55K

Grant

2026-01-15

Harrington Robert Arthur

Director

197 @ $63.44$12K

Grant

2026-01-15

WIERENGA WENDELL

Director

98 @ $63.44$6K

Grant

2026-01-15

HENDERSON JOHN T

Director

334 @ $63.44$21K

Grant

2026-01-15

Wysenski Nancy

Director

98 @ $63.44$6K

Grant

2026-01-15

Daly James M

Director

197 @ $63.44$12K

Grant

2026-01-15

Kaye Edward M. MD

Director

197 @ $63.44$12K

Sell10b5-1

2026-01-05

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $60.28$904K

Exercise10b5-1

2026-01-05

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $23.26$349K

Sell10b5-1

2026-01-02

Callos Andrew

EVP, Chief Commercial Officer

913 @ $62.09$57K

Exercise10b5-1

2026-01-02

Callos Andrew

EVP, Chief Commercial Officer

885 @ $37.63$33K

Sell10b5-1

2026-01-02

Callos Andrew

EVP, Chief Commercial Officer

885 @ $63.16$56K

+ 63 more

Date	Insider	Action	Shares	Price	Value
2026-03-18	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	1,930	$62.07	$120K
2026-03-17	Lee SungEVP, Chief Financial Officer	Sell	4,935	$62.15	$307K
2026-03-17	Malik Fady IbrahamEVP Research & Development	Sell	7,636	$62.15	$475K
2026-03-17	Callos AndrewEVP, Chief Commercial Officer	Sell	5,626	$62.15	$350K
2026-03-17	Callos AndrewEVP, Chief Commercial Officer	Sell	2,916	$62.15	$181K
2026-03-17	Blum Robert IPresident & CEO	Sell	23,928	$62.15	$1.49M
2026-03-17	Malik Fady IbrahamEVP Research & Development	Sell	4,397	$62.15	$273K
2026-03-17	Blum Robert IPresident & CEO	Sell	12,673	$62.15	$788K
2026-03-16	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	1,709	$61.03	$104K
2026-03-15	Lee SungEVP, Chief Financial Officer	Grant	20,646	—	—
2026-03-15	Callos AndrewEVP, Chief Commercial Officer	Grant	20,646	—	—
2026-03-15	Callos AndrewEVP, Chief Commercial Officer	Grant	13,320	—	—
2026-03-15	Callos AndrewEVP, Chief Commercial Officer	Grant	1,665	—	—
2026-03-15	Callos AndrewEVP, Chief Commercial Officer	Grant	29,480	—	—
2026-03-15	Blum Robert IPresident & CEO	Grant	1,665	—	—
2026-03-15	Malik Fady IbrahamEVP Research & Development	Grant	27,306	—	—
2026-03-15	Malik Fady IbrahamEVP Research & Development	Grant	1,665	—	—
2026-03-15	Malik Fady IbrahamEVP Research & Development	Grant	39,527	—	—
2026-03-15	Hessekiel JeffreyChief Legal & Admin Officer	Grant	22,820	—	—
2026-03-15	Hessekiel JeffreyChief Legal & Admin Officer	Grant	8,325	—	—
2026-03-15	Hessekiel JeffreyChief Legal & Admin Officer	Grant	20,646	—	—
2026-03-15	Lee SungEVP, Chief Financial Officer	Grant	29,480	—	—
2026-03-15	Lee SungEVP, Chief Financial Officer	Grant	1,665	—	—
2026-03-15	Blum Robert IPresident & CEO	Grant	111,864	—	—
2026-03-15	Blum Robert IPresident & CEO	Grant	75,258	—	—
2026-03-09	Blum Robert IPresident & CEO	Sell	7,931	$60.72	$482K
2026-03-09	Callos AndrewEVP, Chief Commercial Officer	Sell	2,582	$60.72	$157K
2026-03-09	Malik Fady IbrahamEVP Research & Development	Sell	2,907	$60.72	$177K
2026-03-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	11,000	$61.88	$681K
2026-03-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,000	$61.87	$928K
2026-03-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,000	$23.26	$349K
2026-03-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	11,000	$39.13	$430K
2026-03-02	PARSHALL B LYNNEDirector	Sell10b5-1	5,000	$61.21	$306K
2026-03-02	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	886	$37.63	$33K
2026-03-02	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	886	$61.62	$55K
2026-02-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,000	$23.26	$349K
2026-02-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,000	$61.93	$929K
2026-02-02	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	886	$37.63	$33K
2026-02-02	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	886	$62.10	$55K
2026-01-15	Harrington Robert ArthurDirector	Grant	197	$63.44	$12K
2026-01-15	WIERENGA WENDELLDirector	Grant	98	$63.44	$6K
2026-01-15	HENDERSON JOHN TDirector	Grant	334	$63.44	$21K
2026-01-15	Wysenski NancyDirector	Grant	98	$63.44	$6K
2026-01-15	Daly James MDirector	Grant	197	$63.44	$12K
2026-01-15	Kaye Edward M. MDDirector	Grant	197	$63.44	$12K
2026-01-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,000	$60.28	$904K
2026-01-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,000	$23.26	$349K
2026-01-02	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	913	$62.09	$57K
2026-01-02	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	885	$37.63	$33K
2026-01-02	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	885	$63.16	$56K

+ 63 more transactions

← All catalysts for $CYTK